Detalles de la búsqueda
1.
Sintilimab in Patients with Previously Treated Metastatic Neuroendocrine Neoplasms.
Oncologist
; 27(8): e625-e632, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35647908
2.
Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study.
Cancer Immunol Immunother
; 71(6): 1443-1451, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34689233
3.
Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies.
Oncologist
; 26(12): e2227-e2238, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516729
4.
Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers.
Cancer Immunol Immunother
; 70(9): 2669-2679, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33624146
5.
Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study.
BMC Gastroenterol
; 21(1): 398, 2021 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34688250
6.
Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors.
Chin J Cancer Res
; 32(3): 370-382, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32694901
7.
DNA in serum extracellular vesicles is stable under different storage conditions.
BMC Cancer
; 16(1): 753, 2016 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27662833
8.
The novel HLA-B*51:389 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual.
HLA
; 103(2): e15351, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38318996
9.
[Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer].
Zhonghua Zhong Liu Za Zhi
; 35(9): 666-71, 2013 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-24332053
10.
[Analysis of therapeutic effect and prognosis in patients with metastatic colorectal cancer and different K-ras status].
Zhonghua Zhong Liu Za Zhi
; 35(4): 273-6, 2013 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-23985255
11.
Two neurosubtypes of ADHD different from the clinical phenotypes.
Psychiatry Res
; 328: 115453, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37660582
12.
A combined immune prognostic index in esophageal squamous cell carcinoma patients treated with anti-PD-1 therapy.
Ther Adv Med Oncol
; 15: 17588359231174869, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37333902
13.
Nomogram for tumour response based on prospective cohorts of hepatocellular carcinoma patients receiving immunotherapy combined with targeted therapy: development and validation.
Ann Transl Med
; 11(5): 199, 2023 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37007564
14.
[Clinical analysis of the current treatment status of gastric cancer in 636 patients].
Zhonghua Zhong Liu Za Zhi
; 34(4): 316-20, 2012 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-22781048
15.
[HER-2 expression in advanced gastric cancer and its correlation with clinical features, outcome and prognosis].
Zhonghua Zhong Liu Za Zhi
; 33(9): 671-5, 2011 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-22340047
16.
Post-radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma.
Oncol Lett
; 21(1): 68, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33365079
17.
[Evaluation of bevacizumab combined with irinotecan-based regimen as the first-line treatment for patients with metastatic colorectal cancer].
Zhonghua Zhong Liu Za Zhi
; 32(10): 786-90, 2010 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-21163073
18.
PRSS contributes to cetuximab resistance in colorectal cancer.
Sci Adv
; 6(1): eaax5576, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31911942
19.
Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study.
Clin Cancer Res
; 25(2): 515-523, 2019 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30348638
20.
Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer.
EBioMedicine
; 43: 261-269, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31031019